4:23 PM
 | 
Dec 12, 2018
 |  BC Extra  |  Preclinical News

Allen Institute's immunology division launches with $125M, Lilly vet and five partners

The Allen Institute expects its latest research endeavor to generate knowledge about molecular drivers of immune-related diseases, paving the way for new diagnostics and therapies. The Allen Institute for Immunology launched Wednesday with $125 million from the late Allen Institute founder Paul Allen and tapped Eli Lilly and Co. (NYSE:LLY) drug discovery veteran Thomas Bumol as executive director.

Bumol contributed to drug discovery and early clinical development across several immune-related diseases at...

Read the full 336 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >